SCHEMBL25733917

SCHEMBL25733917

Cc1ccc2cc(-c3cc(S(=O)(=O)N(C)CC(=O)N4CCO[C@@H](CO)C4)ccc3N3CCCC3)[nH]c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STT3A P46977 1/20 0.68
STT3B Q8TCJ2 1/20 0.68
TSHR P16473 4/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
GFER P55789 1/20 0.36
ALDH1A1 P00352 7/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 2/20 0.35
ALOX15 P16050 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ADRB2 P07550 1/20 0.34
ALPL P05186 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25726106 1.00 STT3A (0.68) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25733919 0.92 STT3A (0.66) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25725787 0.91 STT3A (0.72) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25726116 0.91 STT3A (0.72) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25726119 0.91 STT3A (0.72) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25726327 0.89 STT3A (0.67) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25726195 0.88 STT3A (0.66) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25725970 0.88 STT3A (0.78) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25726323 0.86 STT3A (0.73) STT3ASTT3BTSHRMAPK1HTT
SCHEMBL25733880 0.86 STT3A (0.70) STT3ASTT3BTSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114428-A1 HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE Vir Biotechnology, Inc. (US) 2023-06-22 WO disclosed